Human Genome Sciences (HGSI) CEO Said Lupus Drug Could Sell for $20,000/Yr or More
Tweet Send to a Friend
At a UBS conference today Human Genome Sciences Inc. (Nasdaq: HGSI) CEO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


